Anti-Mouse CD366 (Tim-3) - Biotin

Leinco Technologies
Product Code: LEI-T740
Product Group: Primary Antibodies
CodeSizePrice
LEI-T740-100ug100 ug£223.00
Quantity:
LEI-T740-500ug500 ug£598.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rat
Antibody Isotype: IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: RMT3-23
Regulatory Status: RUO
Target Species: Mouse
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This biotinylated antibody is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
Tim-3 is expressed on activated Th1 and Tc1 lymphocytes, CD11b+ macrophages, Tregs, NK cells, and mast cells.
Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Biotin
Format:
This biotinylated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This biotinylated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
This antibody was produced using recombinant mouse TIM-3
Long Description:
Tim-3 antibody, clone RMT3-23, recognizes T cell immunoglobulin and mucin domain-containing protein 3 (TIM3, also known as CD366), a TIM family member of immunoregulatory proteins. Tim-3 is a 60kDa type I transmembrane protein with an extracellular immunoglobulin and mucin-like domain and a cytoplasmic tyrosine phosphorylation motif. Tim-3 is expressed by IFNg-producing Th1 CD4 and Tc1 (cytotoxic) CD8 T cells1, regulatory T cells (Tregs)2, myeloid cells3, NK cells4, and mast cells5. Tim-3 is an inhibitory molecule that limits Th1-mediated inflammatory diseases, including a model of central nervous system inflammation (experimental autoimmune encephalomyelitis, EAE)1, inflammatory bowel disease (IBD)6, and type I diabetes7. Tim-3 is also proposed to induce immunological tolerance7, promote Th1 apoptosis8, and regulate macrophage activation1. In addition, Tim-3 is upregulated on tumor-infiltrating lymphocytes, and coblockade of Tim-3 and immune checkpoint inhibitors, such as PD-1, is currently being investigated in clinical trials for the treatment of cancer9.
NCBI Gene:
171285
Target:
Tim-3

References

1. Monney, L. et al. (2002)Nature 415, 536?541. 2. Gao, X. et al. (2012) PLOS ONE 7, e30676. 3. Anderson, A. C. et al. (2007) Science 318, 1141?1143. 4. Ndhlovu, L. C. et al. (2012) Blood 119, 3734?3743. 5. Phong, B. L. et al. J. (2015) Exp. Med. 212, 2289?2304. 6. Li, X. et al. (2010) Clin. Immunol. 134, 169?177. 7. Sanchez-Fueyo, A. et al. (2003) Nat. Immunol. 4, 1093?1101. 8. Zhu C, et al.. Nature Immunology. 2005;6:1245?1252.

Related Products

Product NameProduct CodeSupplier 
Anti-Mouse CD32/CD16 - Purified (Fc Block Antibody)LEI-C247Leinco Technologies Summary Details
FCM Staining Buffer (BSA) (10X)LEI-F1175Leinco Technologies Summary Details
Rat IgG2a Isotype Control - Purified in vivo GOLD™ Functional GradeLEI-I-1177Leinco Technologies Summary Details
Goat Anti-Rat IgG (H&L) (Adsorbed Against: Hu., Rb., Bv., Hs.) - BiotinLEI-R1214Leinco Technologies Summary Details
RBC Lysing Buffer 'Ready to Use'LEI-R1364Leinco Technologies Summary Details
Streptavidin - PE, Premium GradeLEI-S211Leinco Technologies Summary Details
Streptavidin - APCLEI-S571Leinco Technologies Summary Details